|
Astrocytic
Tumors
|
|
|
|
|
Alba A. Brandes, Linda Nicolardi,
Alicia Tosoni, Marina Gardiman, Paolo Iuzzolino,
Claudio Ghimenton, Michele Reni, Antonino
Rotilio, Guido Sotti and Mario Ermani
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
Abstract
|
Full
Text | 
Reprint
|
|
Marc Frenay,
C Lebrun, D Fontaine, V Bourg, A Ramaioli, PY Marcy, F Peyrade, JF Michiels
First-line chemotherapy in non resectable low-grade
astrocytomas in adults
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2095
|
|
Medical
Research Council Brain Tumor Working Party
Randomized trial
of procarbazine, lomustine, and vincristine in the adjuvant treatment of
high-grade astrocytoma: a Medical Research Council trial
J Clin Oncol 2001 Jan 15;19(2):509-18 (PDF Full Text)
|
|
Prados
MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R,
Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr
A
phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and
vincristine (PCV) with or without BUdR for the treatment of anaplastic
astrocytoma: a preliminary report of RTOG 9404
Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15
|
|
Michael D. Prados, Charles Scott,
Walter J. Curran, Jr, Diana F. Nelson, Steve
Leibel, Simon Kramer
Procarbazine, Lomustine, and Vincristine (PCV) Chemotherapy for Anaplastic
Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group
Protocols Comparing Survival With Carmustine or PCV Adjuvant Chemotherapy
Journal of Clinical Oncology,
Vol 17, Issue 11 (November 1), 1999: 3389-3395. (PDF Full Text)
|
|
|
Gliomas
|
|
|
|
M
Brada,
DG Thomas, NM Bleehen, JT Roberts, F Senanayake, P Abram, PL Lantos, TH Moss, JW
Ironside, JB Whaley, SP Stenning
Medical Research Council (MRC) Randomised Trial of
Adjuvant Chemotherapy in High Grade Glioma (HGG)
ASCO
Proceedings, 1998 Annual Meeting,
Abstract No. 1543
|
|
Chamberlain
MC, Jaeckle KA
Medical
Research Council adjuvant trial in high-grade gliomas
J Clin Oncol 2001 Oct 1;19(19):3997-9 (PDF Full Text)
|
|
Levin
VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK,
Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW
Phase
III randomized study of postradiotherapy chemotherapy with combination
alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas
Clin Cancer Res. 2003
Mar;9(3):981-90 (PDF
Full Text)
|
|
Levin
VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson
CB
Radiation
therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine,
and vincristine for the treatment of anaplastic gliomas
Int J Radiat Oncol Biol Phys 1995 Apr 30;32(1):75-83
|
|
Levin
VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB
Superiority
of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and
vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
Int
J Radiat Oncol Biol Phys 1990 Feb;18(2):321-4
|
|
|
A. Pace, A. Pompili, M.
Maschio, E. Galie', S. Telera, B. Jandolo, E. Occhipinti, C. M. Carapella
PCV and/or TMZ chemotherapy in 255
gliomas. Analysis of the clinical experience from a neuro-oncology
data-base
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1538
|
|
|
Gliomas
(Low Grade)
|
|
|
|
Buckner
JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R,
Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R
Phase
II trial of procarbazine, lomustine, and vincristine as initial therapy for
patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and
associations with chromosomal abnormalities
J Clin Oncol 2003 Jan 15;21(2):251-5 (PDF Full Text)
|
|
Stege
EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van
der Rijt CD, Smitt PA, van den Bent MJ
Successful
treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of
procarbazine, lomustine, and vincristine
Cancer. 2005
Feb 15;103(4):802-9.
|
|
|
Glioblastoma
|
|
|
|
Boiardi
A
PCV chemotherapy for recurrent glioblastoma
multiforme
Neurology 2001 Jun 26;56(12):1782
|
|
|
Alba A. Brandes, Mario Ermani, Umberto Basso,
Myriam K. Paris, Franco Lumachi, Franco Berti,
Pietro Amistą, Marina Gardiman, Paolo Iuzzolino,
Sergio Turazzi, Silvio Monfardini
Temozolomide in Patients with Glioblastoma at Second Relapse after First Line
Nitrosourea-Procarbazine Failure: A Phase II Study
Oncology,
Vol. 63, No. 1,
38-41, August 2002
Abstract |
DBLinks | BL
1:3
|
|
Kappelle
AC, Postma TJ, Taphoorn MJ, Groeneveld GJ, van den Bent MJ, van Groeningen
CJ, Zonnenberg BA, Sneeuw KC, Heimans JJ
PCV
chemotherapy for recurrent glioblastoma multiforme
Neurology 2001 Jan 9;56(1):118-20 (PDF
Full Text)
|
|
Levin
VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds
N, Woo S, Rodriguez L, et al
Phase
II study of accelerated fractionation radiation therapy with carboplatin
followed by vincristine chemotherapy for the treatment of glioblastoma
multiforme
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):357-64
|
|
Nieder C
Treatment of newly diagnosed glioblastoma
multiforme
J Clin Oncol. 2002 Jul 15;20(14):3179-80; author reply 3181-2. (PDF
Full Text)
|
|
R.
Soffietti, A. Costanza, E. Laguzzi, M. Nobile, R. Rudą;
A phase II study of first-line
temozolomide and second-line PCV in recurrent/progressive malignant
gliomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1574
|
|
|
Oligo
Tumors & Mixed Gliomas
|
|
|
|
|
Martin J. van den Bent, Antoine
F. Carpentier, Alba A. Brandes, Marc Sanson,
Martin J.B. Taphoorn, Hans J.J.A. Bernsen, Marc
Frenay, Cees C. Tijssen, Wolfgang Grisold, Laslo
Sipos, Hanny Haaxma-Reiche, Johannes M. Kros,
Mathilde C.M. van Kouwenhoven, Charles J. Vecht, Anouk
Allgeier, Denis Lacombe, Thierry Gorlia
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free
Survival but Not Overall Survival in Newly Diagnosed Anaplastic
Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation
for Research and Treatment of Cancer Phase III Trial
Journal of Clinical Oncology, Vol 24, No 18 (June
20), 2006: pp. 2715-2722. DOI:
10.1200/JCO.2005.04.6078
|
|
M. J.
van den Bent, J. Delattre, A. A. Brandes, M. J. Taphoorn, K. Hoang
Xuan, H. Bernsen, M. Frenay, W. Grisold, T. Gorlia, D. Lacombe
First analysis of EORTC trial
26951, a randomized phase III study of adjuvant PCV chemotherapy in
patients with highly anaplastic oligodendroglioma
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1503.
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1503
|
|
M
J van den Bent, O Chinot, W Boogerd, J Bravo-Marques, MJB Taphoorn, JM Kros, CDD
van de Rijt, N de Beule, B Baron, On Behalf of the EORTC Brain Tumor Group.
EORTC
Study 26972: Second Line Temozolomide Chemotherapy in Recurrent Oligodendroglial
Tumors After PCV Chemotherapy: a Phase II Study
ASCO Proceedings, 2001 Annual Meeting, Abstract No. 203
|
|
|
Gregory Cairncross, Brian
Berkey, Edward Shaw, Robert Jenkins, Bernd
Scheithauer, David Brachman, Jan Buckner, Karen
Fink, Luis Souhami, Normand Laperierre, Minesh
Mehta, Walter Curran
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy
Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation
Therapy Oncology Group Trial 9402
Journal of Clinical Oncology, Vol 24, No 18 (June
20), 2006: pp. 2707-2714. DOI:
10.1200/JCO.2005.04.3414
|
|
G. Cairncross, W. Seiferheld, E. Shaw, R. Jenkins, B. Scheithauer, D. Brachman,
J. Buckner, K. Fink, L. Souhami, W. Curran
An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus
radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas:
Initial report of RTOG 94-02
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1500
|
|
|
Mark R. Gilbert, Frederick F.
Lang
Anaplastic Oligodendroglial Tumors: A Tale of Two Trials
Journal of Clinical Oncology, Vol 24, No 18 (June
20), 2006: pp. 2689-2690. DOI:
10.1200/JCO.2006.05.8594
|
|
Jeremic B, Milicic B, Grujicic D, Samardzic M,
Antunovic V, Dagovic A, Aleksandrovic J
Combined treatment
modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year
update of a phase II study
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):509-14.
|
|
Ozyigit
G, Onal
C, Gurkaynak
M, Soylemezoglu
F, Zorlu
F
Postoperative radiotherapy and chemotherapy in the
management of oligodendroglioma: single institutional review of 88 patients
J Neurooncol. 2005 Nov;75(2):189-93.
|
|
|
|
